ERBB2 and neoplasm: Ladjohounlou et al. [22] compared the anti-tumour efficacy and toxicity of non-internalizing (anti-CEA) and internalizing (anti-HER2) 212Pb-labelled mAbs during α-radioimmunotherapy (α-RIT) of small-volume peritoneal carcinomatosis.